Hakutulokset - Alan Fix

Tarkenna hakua
  1. 1
    Economic Impact of Lyme Disease

    Economic Impact of Lyme Disease Tekijä Xinzhi Zhang, Martin I. Meltzer, César Peña, Annette Hopkins, Lane Wroth, Alan Fix

    Julkaistu 2006
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    Role of hepatitis C infection in chronic liver disease in Egypt.

    Role of hepatitis C infection in chronic liver disease in Egypt. Tekijä G. Thomas Strickland, Hanaa Elhefni, Tary Salman, Imam Waked, Mohamed Abdel-Hamid, Nabiel Mikhail, Gamal Esmat, Alan Fix

    Julkaistu 2002
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    Comparison of Second- and Third-Generation Enzyme Immunoassays for Detecting Antibodies to Hepatitis C Virus

    Comparison of Second- and Third-Generation Enzyme Immunoassays for Detecting Antibodies to Hepatitis C Virus Tekijä Mohamed Abdel‐Hamid, Mai M. El-Daly, Sherif A. El‐Kafrawy, Nabiel Mikhail, G. Thomas Strickland, Alan Fix

    Julkaistu 2002
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    Safety and immunogenicity of a parenterally administered rotavirus VP8 subunit vaccine in healthy adults

    Safety and immunogenicity of a parenterally administered rotavirus VP8 subunit vaccine in healthy adults Tekijä Alan Fix, Clayton Harro, Monica McNeal, Len Dally, Jorge Flores, George A. Robertson, John W. Boslego, Stanley Cryz

    Julkaistu 2015
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    Intrafamilial transmission of hepatitis C in Egypt

    Intrafamilial transmission of hepatitis C in Egypt Tekijä M.K. Mohamed, Mohamed Abdel‐Hamid, Nabiel Mikhail, Fatma Abdel-Aziz, Ahmed Medhat, Laurence S. Magder, Alan Fix, Thomas H. Strickland

    Julkaistu 2005
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    Hepatitis C in a community in Upper Egypt: I. Cross-sectional survey.

    Hepatitis C in a community in Upper Egypt: I. Cross-sectional survey. Tekijä M Nafeh, Ahmed Medhat, Mohamed Shehata, Nabiel Mikhail, YoussefM Swifee, Mohamed Abdel-Hamid, Sheldon Watts, Alan Fix, G. Thomas Strickland, Wagida A. Anwar, Ismail Sallam

    Julkaistu 2000
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    Cholera in Lima, Peru, Correlates with Prior Isolation of Vibrio cholerae from the Environment

    Cholera in Lima, Peru, Correlates with Prior Isolation of Vibrio cholerae from the Environment Tekijä Augusto A. Franco, Alan Fix, Ana Prada, Eduar Bravo Paredes, Juan Carlos Palomino, Anita C. Wright, J. A. Johnson, Robert McCarter, Humberto Guerra, J. Glenn Morris

    Julkaistu 1997
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled trial

    Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled trial Tekijä Michelle J. Groome, Anthonet Koen, Alan Fix, Nicola Page, Lisa Jose, Shabir A. Madhi, Monica McNeal, Len Dally, Iksung Cho, Maureen Power, Jorge Flores, Stanley Cryz

    Julkaistu 2017
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  9. 9
    Hepatitis C virus(HCV) infection in a community in the nile delta: Population description and HCV prevalence

    Hepatitis C virus(HCV) infection in a community in the nile delta: Population description and HCV prevalence Tekijä Fatma Abdel-Aziz, Mostafa Habib, Mostafa K. Mohamed, Mohamed Abdel‐Hamid, F Gamil, Salah Madkour, Nabiel Mikhail, David L. Thomas, Alan Fix, T. Strickland, Wagida A. Anwar, Ismail Sallam

    Julkaistu 2000
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  10. 10
    Hepatitis C virus infection in a community in the Nile Delta: Risk factors for seropositivity

    Hepatitis C virus infection in a community in the Nile Delta: Risk factors for seropositivity Tekijä Mostafa Habib, Mostafa K. Mohamed, Fatma Abdel‐Aziz, Laurence S. Magder, Mohamed Abdel‐Hamid, F Gamil, Salah Madkour, Nabiel Mikhail, Wagida A. Anwar, G. Thomas Strickland, Alan Fix, Ismail Sallam

    Julkaistu 2001
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  11. 11
    Data and Safety Monitoring of COVID-19 Vaccine Clinical Trials

    Data and Safety Monitoring of COVID-19 Vaccine Clinical Trials Tekijä Steven Joffe, Abdel G. Babiker, Susan S. Ellenberg, Alan Fix, Marie R. Griffin, Sally Hunsberger, Jorge Kalil, Myron M. Levine, Malegapuru W. Makgoba, Reneé H. Moore, Anastasios A. Tsiatis, Richard J. Whitley

    Julkaistu 2021
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  12. 12
    Live attenuated enterotoxigenic Escherichia coli (ETEC) vaccine with dmLT adjuvant protects human volunteers against virulent experimental ETEC challenge

    Live attenuated enterotoxigenic Escherichia coli (ETEC) vaccine with dmLT adjuvant protects human volunteers against virulent experimental ETEC challenge Tekijä Clayton Harro, A. Louis Bourgeois, David A. Sack, Richard I. Walker, Barbara DeNearing, Jessica Brubaker, Nicole Maier, Alan Fix, Len Dally, Subhra Chakraborty, John D. Clements, Ingelise Saunders, Michael J. Darsley

    Julkaistu 2019
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  13. 13
    Safety and immunogenicity of a parenteral trivalent P2-VP8 subunit rotavirus vaccine: a multisite, randomised, double-blind, placebo-controlled trial

    Safety and immunogenicity of a parenteral trivalent P2-VP8 subunit rotavirus vaccine: a multisite, randomised, double-blind, placebo-controlled trial Tekijä Michelle J. Groome, Lee Fairlie, Julie Morrison, Alan Fix, Anthonet Koen, Maysseb Masenya, Lisa Jose, Shabir A. Madhi, Nicola Page, Monica McNeal, Len Dally, Iksung Cho, Maureen Power, Jorge Flores, Stanley Cryz

    Julkaistu 2020
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  14. 14
    Active Surveillance for Acute Viral Hepatitis in Rural Villages in the Nile Delta

    Active Surveillance for Acute Viral Hepatitis in Rural Villages in the Nile Delta Tekijä Fatma Abdel Salam Meky, Sonia Stoszek, M. Abdel Hamid, Samy Selim, Asrul Abdul Wahab, Nabiel Mikhail, Sherif A. El‐Kafrawy, Mai M. El-Daly, M. Kamal, Samar M. Sharaf, M.K. Mohamed, Ronald E. Engle, Suzanne U. Emerson, Robert H. Purcell, Alan Fix, G. Thomas Strickland

    Julkaistu 2006
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  15. 15
    Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo-controlled phase 1/2 trial

    Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo-controll... Tekijä Firdausi Qadri, Marjahan Akhtar, Taufiqur Rahman Bhuiyan, Mohiul Islam Chowdhury, Tasnuva Ahmed, Tanzeem Ahmed Rafique, Arifuzzaman Khan, Sadia Rahman, Farhana Khanam, Anna Lundgren, Gudrun Wiklund, Joanna Kaim, Madeleine Löfstrand, Nils Carlin, A. Louis Bourgeois, Nicole Maier, Alan Fix, Thomas F. Wierzba, Richard I. Walker, Ann–Mari Svennerholm

    Julkaistu 2019
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  16. 16
    Safety of the novel oral poliovirus vaccine type 2 (nOPV2) in infants and young children aged 1 to <5 years and lot-to-lot consistency of the immune response to nOPV2 in infants in The Gambia: a phase 3, double-blind, randomised controlled trial

    Safety of the novel oral poliovirus vaccine type 2 (nOPV2) in infants and young children aged 1 to <5 years and lot-to-lot consistency of the immune response to nOPV2 in infants... Tekijä Magnus Ochoge, Ahmed Futa, Ama Umesi, Lucy Affleck, Larry Kotei, Baboucarr Daffeh, Ebrima Saidy-Jah, Anna Njie, Oluwafemi Temitayo Oyadiran, Bassey Edem, Musa Jallow, Edrissa Jallow, Simon Donkor, Erman Tritama, Talha Abid, Kathryn A V Jones, Bernardo A. Mainou, John Konz, Alan Fix, Chris Gast, Ed Clarke

    Julkaistu 2024
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  17. 17
    Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials

    Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical tri... Tekijä Xavier Sáez‐Llorens, Ananda S Bandyopadhyay, Christopher Gast, Tirza De León, Rodrigo DeAntonio, José Jimeno, Maria Isabel Caballero, Gabriela Aguirre, M. Steven Oberste, William C. Weldon, Jennifer L. Konopka‐Anstadt, John F. Modlin, Novilia Sjafri Bachtiar, Alan Fix, John Konz, Ralf Clemens, Sue Ann Costa Clemens, Ricardo Rüttimann

    Julkaistu 2020
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  18. 18
    Evaluation of the safety and immunogenicity of the oral inactivated multivalent enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi adults in a double-blind, randomized, placebo-controlled Phase I trial using electrochemiluminescence and ELISA assays for immunogenicity analyses

    Evaluation of the safety and immunogenicity of the oral inactivated multivalent enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi adults in a double-blind, randomized,... Tekijä Marjahan Akhtar, Mohiul Islam Chowdhury, Taufiqur Rahman Bhuiyan, Joanna Kaim, Tasnuva Ahmed, Tanzeem Ahmed Rafique, Arifuzzaman Khan, Sadia Rahman, Farhana Khanam, Yasmin Ara Begum, Mir Z. Sharif, Laila N. Islam, Nils Carlin, Nicole Maier, Alan Fix, Thomas F. Wierzba, Richard I. Walker, A. Louis Bourgeois, Ann–Mari Svennerholm, Firdausi Qadri, Anna Lundgren

    Julkaistu 2018
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  19. 19
    Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials

    Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials Tekijä Ilse De Coster, Isabel Leroux‐Roels, Ananda S Bandyopadhyay, Christopher Gast, Kanchanamala Withanage, Katie Steenackers, Philippe De Smedt, Annelies Aerssens, Geert Leroux‐Roels, M. Steven Oberste, Jennifer L. Konopka‐Anstadt, William C. Weldon, Alan Fix, John Konz, Rahnuma Wahid, John F. Modlin, Ralf Clemens, Sue Ann Costa Clemens, Novilia Sjafri Bachtiar, Pierre Van Damme

    Julkaistu 2020
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  20. 20
    Fecal Shedding of 2 Novel Live Attenuated Oral Poliovirus Type 2 Vaccine Candidates by Healthy Infants Administered Bivalent Oral Poliovirus Vaccine/Inactivated Poliovirus Vaccine: 2 Randomized Clinical Trials

    Fecal Shedding of 2 Novel Live Attenuated Oral Poliovirus Type 2 Vaccine Candidates by Healthy Infants Administered Bivalent Oral Poliovirus Vaccine/Inactivated Poliovirus Vaccine:... Tekijä Christopher Gast, Ananda S Bandyopadhyay, Xavier Sáez‐Llorens, Tirza De León, Rodrigo DeAntonio, José Jimeno, Gabriela Aguirre, Larin McDuffie, Elizabeth Coffee, Demetrius L. Mathis, M. Steven Oberste, William C. Weldon, Jennifer L. Konopka‐Anstadt, John F. Modlin, Novilia Sjafri Bachtiar, Alan Fix, John Konz, Ralf Clemens, Sue Ann Costa Clemens, Ricardo Rüttimann

    Julkaistu 2021
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: